160 related articles for article (PubMed ID: 23268391)
21. Echinacoside promotes bone regeneration by increasing OPG/RANKL ratio in MC3T3-E1 cells.
Li F; Yang Y; Zhu P; Chen W; Qi D; Shi X; Zhang C; Yang Z; Li P
Fitoterapia; 2012 Dec; 83(8):1443-50. PubMed ID: 22951288
[TBL] [Abstract][Full Text] [Related]
22. [Expressions of RANK, RANKL, and osteoprotegerin in male rats at different ages].
Zhou XW; Liu YC; Jian XC; Lei YH; Wu Y
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Sep; 31(9):1539-42. PubMed ID: 21945761
[TBL] [Abstract][Full Text] [Related]
23. Areca nut extracts modulated expression of alkaline phosphatase and receptor activator of nuclear factor kappaB ligand in osteoblasts.
Ling LJ; Ho FC; Chen YT; Holborow DW; Liu TY; Hung SL
J Clin Periodontol; 2005 Apr; 32(4):353-9. PubMed ID: 15811051
[TBL] [Abstract][Full Text] [Related]
24. Protein phosphatase 2A Cα is involved in osteoclastogenesis by regulating RANKL and OPG expression in osteoblasts.
Okamura H; Yang D; Yoshida K; Haneji T
FEBS Lett; 2013 Jan; 587(1):48-53. PubMed ID: 23183242
[TBL] [Abstract][Full Text] [Related]
25. Effect of whey protein on the proliferation and differentiation of osteoblasts.
Xu R
J Dairy Sci; 2009 Jul; 92(7):3014-8. PubMed ID: 19528578
[TBL] [Abstract][Full Text] [Related]
26. Expression of osteoprotegerin and receptor activator of nuclear factor-kappaB ligand (RANKL) in HCC70 breast cancer cells and effects of treatment with gonadotropin-releasing hormone on RANKL expression.
Schubert A; Schulz H; Emons G; Gründker C
Gynecol Endocrinol; 2008 Jun; 24(6):331-8. PubMed ID: 18584413
[TBL] [Abstract][Full Text] [Related]
27. [Effects of calcitonin on osteoblast cell proliferation and OPG/RANKL expression: experiment with mouse osteoblasts].
Tian QX; Huang GY; Zhou JL; Liu QH; DU XR
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1501-5. PubMed ID: 17785093
[TBL] [Abstract][Full Text] [Related]
28. Adiponectin stimulates RANKL and inhibits OPG expression in human osteoblasts through the MAPK signaling pathway.
Luo XH; Guo LJ; Xie H; Yuan LQ; Wu XP; Zhou HD; Liao EY
J Bone Miner Res; 2006 Oct; 21(10):1648-56. PubMed ID: 16995820
[TBL] [Abstract][Full Text] [Related]
29. Osteoprotegerin/RANK/RANKL axis in cardiac remodeling due to immuno-inflammatory myocardial disease.
Liu W; Feng W; Wang F; Li W; Gao C; Zhou B; Ma M
Exp Mol Pathol; 2008 Jun; 84(3):213-7. PubMed ID: 18417124
[TBL] [Abstract][Full Text] [Related]
30. [Osteoprotegerin mRNA/receptor activator of NF-kappaB ligand mRNA expressions in bone tissues of glucocorticoid-induced osteonecrosis of the femoral head].
Wang J; Wang K; Shi Z; Zhang M
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Oct; 22(10):1161-4. PubMed ID: 18979868
[TBL] [Abstract][Full Text] [Related]
31. Enamel matrix derivative neutralized the effect of lipopolysaccharide on osteoprotegerin and receptor activator of nuclear factor kappa B ligand expression of osteoblasts.
Wada Y; Mizuno M; Tamura M
Arch Oral Biol; 2009 Apr; 54(4):306-12. PubMed ID: 19201394
[TBL] [Abstract][Full Text] [Related]
32. [Expression of receptor activator of nuclear factor kappaB ligand and osteoprotegerin of mice osteoblast induced by metal ions].
Dai M; Yuan X; Fan H; Cheng M; Ai J
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2010 Mar; 24(3):292-5. PubMed ID: 20369527
[TBL] [Abstract][Full Text] [Related]
33. [The function of bushen qiangdu recipe containing serum in OPG/RANKL pathway of ankylosing spondylitis patients].
Xu Y; Ya XP; Zhang WJ
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Apr; 32(4):521-4. PubMed ID: 22803436
[TBL] [Abstract][Full Text] [Related]
34. Membrane-bound receptor activator of NFκB ligand (RANKL) activity displayed by osteoblasts is differentially regulated by osteolytic factors.
Singh PP; van der Kraan AG; Xu J; Gillespie MT; Quinn JM
Biochem Biophys Res Commun; 2012 May; 422(1):48-53. PubMed ID: 22561018
[TBL] [Abstract][Full Text] [Related]
35. Megakaryocytes modulate osteoblast synthesis of type-l collagen, osteoprotegerin, and RANKL.
Bord S; Frith E; Ireland DC; Scott MA; Craig JI; Compston JE
Bone; 2005 May; 36(5):812-9. PubMed ID: 15794927
[TBL] [Abstract][Full Text] [Related]
36. [Immunolocalization of receptor activator of NF-kappaB ligand and osteoprotegerin during mouse mandibular first molar eruption].
Wu L; Hua F; Zhang XL; Zhang L; Chen Z
Zhonghua Kou Qiang Yi Xue Za Zhi; 2008 Mar; 43(3):164-7. PubMed ID: 18788552
[TBL] [Abstract][Full Text] [Related]
37. Expression profiles of receptor activator of nuclear factor kappaB ligand, receptor activator of nuclear factor kappaB, and osteoprotegerin messenger RNA in aged and ovariectomized rat bones.
Ikeda T; Utsuyama M; Hirokawa K
J Bone Miner Res; 2001 Aug; 16(8):1416-25. PubMed ID: 11499864
[TBL] [Abstract][Full Text] [Related]
38. Osteoprotegerin, RANKL, and bone turnover in primary hyperparathyroidism: the effect of parathyroidectomy and treatment with alendronate.
Szymczak J; Bohdanowicz-Pawlak A
Horm Metab Res; 2013 Sep; 45(10):759-64. PubMed ID: 23888411
[TBL] [Abstract][Full Text] [Related]
39. Cobalt and chromium ions reduce human osteoblast-like cell activity in vitro, reduce the OPG to RANKL ratio, and induce oxidative stress.
Zijlstra WP; Bulstra SK; van Raay JJ; van Leeuwen BM; Kuijer R
J Orthop Res; 2012 May; 30(5):740-7. PubMed ID: 22025323
[TBL] [Abstract][Full Text] [Related]
40. The synergistic effects of IL-6/IL-17A promote osteogenic differentiation by improving OPG/RANKL ratio and adhesion of MC3T3-E1 cells on hydroxyapatite.
Sritharan S; Kannan TP; Norazmi MN; Nurul AA
J Craniomaxillofac Surg; 2018 Aug; 46(8):1361-1367. PubMed ID: 29805067
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
